RxDoctor Payments Data

Lindsey Jenkins, PA

Physician Assistant · Longview, TXNPI 1891430443

Payments from drug & device makers

$2,995in general payments, 2019–2025

Across 149 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$853
  • Novartis$678
  • GSK$329
  • AstraZeneca$292
  • Genentech USA, Inc.$196
  • CSL Behring$156
  • plus $490 from 10 others

What the payments were for

  • Food & beverage$2,87896%
  • Education$1174%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,995 in reported general payments places this provider in the 80th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$42,851
Medicare patients
189
Services billed
5,012

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NucalaMepolizumab11$41,385
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$36,438
XolairOmalizumab12$32,446
SymbicortBudesonide/Formoterol Fumarate39$8,811
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$6,449
Ipratropium Bromide176$5,542
Advair HfaFluticasone Propion/Salmeterol17$5,245
Azelastine Hcl77$3,137
Montelukast Sodium280$2,283
Fluticasone Propionate151$2,186
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$1,917
Famotidine115$1,391
Albuterol Sulfate HfaAlbuterol Sulfate32$1,244
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$980
Ventolin HfaAlbuterol Sulfate15$806

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKNucala, Trelegy Ellipta$329$77,82356 claims
AstraZenecaSymbicort, Breztri Aerosphere$292$15,26050 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Longview

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →